Suliman Shehnaaz: insider trades.
Suliman Shehnaaz reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($605K), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- SULIMAN SHEHNAAZ
Companies
| Company | Relationship | Transactions |
|---|---|---|
| 10x Genomics, Inc. (TXG) | Director | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-22 | 10x Genomics, Inc. | S | 1,325 | $80.82 | 27,284 | Form 4 |
| 2026-09-22 | 10x Genomics, Inc. | S | 2,270 | $81.67 | 25,014 | Form 4 |
| 2026-09-22 | 10x Genomics, Inc. | S | 292 | $78.2 | 29,223 | Form 4 |
| 2026-09-22 | 10x Genomics, Inc. | S | 614 | $79.51 | 28,609 | Form 4 |
| 2026-09-22 | 10x Genomics, Inc. | S | 1,222 | $82.28 | 23,792 | Form 4 |
| 2026-08-24 | 10x Genomics, Inc. | S | 561 | $62.73 | 31,161 | Form 4 |
| 2026-08-24 | 10x Genomics, Inc. | S | 1,646 | $63.97 | 29,515 | Form 4 |
Questions
What stock did Suliman Shehnaaz buy or sell?
Suliman Shehnaaz reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($605K), across 1 company.
Is Suliman Shehnaaz the same person as other filers with this name?
This page covers SEC CIK 1713070 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/suliman-shehnaaz-1713070.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.